C12Y 404/01011
Methionine gamma-lyase
Official title: Methionine gamma-lyase (4.4.1.11)
C12Y404/01011 (Methionine gamma-lyase) appears on 19 US grants and 35 published applications in this corpus.
Search patents in C12Y- Granted patents
- 19
- Published applications
- 35
- Assignees
- 22
- Inventors
- 78
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 2 |
| 2015 | 3 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 3 |
| 2019 | 1 | 5 |
| 2020 | 1 | 0 |
| 2021 | 2 | 5 |
| 2022 | 3 | 4 |
| 2023 | 1 | 4 |
| 2024 | 4 | 4 |
| 2025 | 1 | 4 |
By publication year.
Recent patents
- Use of genetically engineered strain VNP20009-M in preventing and treating cancer metastasis25 Nov 2025US 12,478,664 B2Guangzhou Sinogen Pharmaceutical Co., Ltd
- Engineered methionine gamma lyase variants8 Oct 2024US 12,110,521 B2Syntis Bio, Inc.
- Composition for the treatment of COVID-19 infection, and a method of treatment2 Jul 2024US 12,023,370 B2AntiCancer, Inc.
- Composition for preventing age-related metabolic and tissue degenerative changes16 Jan 2024US 11,873,519 B2
- Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof2 Jan 2024US 11,859,189 B2Ginkgo Bioworks, Inc.
- Methods and compositions for methionine restriction20 Nov 2025US 2025/0352625 A1Petri Bio, Inc.
- Recombinant methioninase in the treatment of cancer2 Oct 2025US 2025/0302813 A1AntiCancer, Inc.
- Multimeric protein-albumin conjugate, preparation method therefor, and use thereof18 Sep 2025US 2025/0288686 A1Proabtech Inc.
- Engineered methionine gamma lyase variants27 Mar 2025US 2025/0101401 A1Syntis Bio, Inc.
- Method and composition for the treatment of cancer11 Apr 2024US 2024/0115673 A1AntiCancer, Inc.
Most cited
By later US patents
- Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith34US 9,200,251 B12015
- Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith21US 9,365,625 B12016
- Method of treatment using a pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and its cofactor2US 10,046,009 B2Erytech Pharma · 2018
- Orally administered composition to lower serum methionine levels and method of use2US 11,001,826 B2AntiCancer, Inc. · 2021
- Method of treating a mammal, including human, against cancer using methionine and asparagine depletion2US 11,141,468 B2Erytech Pharma · 2021